129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This research is a study to test the reliability of Hyperpolarized Xenon MRI (HXe MRI) as a
biomarker in interstitial lung disease. The study is a non-randomized study to evaluate the
test-retest performance of HXe MRI in Idiopathic Pulmonary Fibrosis (IPF) and chronic
Hypersensitivity Pneumonitis (cHP) as a non-invasive biomarker of disease severity and
prognosis. The study will include approximately 15 subjects with IPF, 15 subjects with cHP
and 10 sex and age-matched normal controls performed across 3 sites.
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas Medical Center
Collaborators:
Boehringer Ingelheim Children's Hospital Medical Center, Cincinnati Duke University